Partial gene suppression improves identification of cancer vulnerabilities when CRISPR-Cas9 knockout is pan-lethal

被引：0
|
作者：
J. Michael Krill-Burger
Joshua M. Dempster
Ashir A. Borah
Brenton R. Paolella
David E. Root
Todd R. Golub
Jesse S. Boehm
William C. Hahn
James M. McFarland
Francisca Vazquez
Aviad Tsherniak
机构：
[1] Broad Institute of Harvard and MIT,
[2] Dana-Farber Cancer Institute,undefined
[3] Harvard Medical School,undefined
来源：
Genome Biology | / 24卷
关键词：
Functional genomics; Cancer genomics; Target identification; RNAi; CRISPR-Cas systems; CRISPR-Cas9 genome editing; Drug discovery;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [11] Identification of genes associated with SiHa cell sensitivity to paclitaxel by CRISPR-Cas9 knockout screening
    Wei, Wei
    He, Yue
    Wu, Yu-Mei
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2018, 11 (04): : 1972 - 1978
  • [12] CRISPR-Cas9 Protocol for Efficient Gene Knockout and Transgene-free Plant Generation
    Perk, Enzo A.
    Laxalt, Ana M.
    Cerrudo, Ignacio
    BIO-PROTOCOL, 2024, 14 (11):
  • [13] Induction of an immortalized songbird cell line allows for gene characterization and knockout by CRISPR-Cas9
    Matthew T. Biegler
    Olivier Fedrigo
    Paul Collier
    Jacquelyn Mountcastle
    Bettina Haase
    Hagen U. Tilgner
    Erich D. Jarvis
    Scientific Reports, 12
  • [14] Combinatorial CRISPR-Cas9 gene knockout to enable genetic interaction mapping in human cells
    Shen, John Paul
    Zhao, Dongxin
    Sasik, Roman
    Luebeck, Jens
    Bojorquez-Gomez, Ana
    Licon, Katherine
    Ideker, Trey
    Mali, Prashant
    CANCER RESEARCH, 2017, 77
  • [15] Induction of an immortalized songbird cell line allows for gene characterization and knockout by CRISPR-Cas9
    Biegler, Matthew T.
    Fedrigo, Olivier
    Collier, Paul
    Mountcastle, Jacquelyn
    Haase, Bettina
    Tilgner, Hagen U.
    Jarvis, Erich D.
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [16] Exposing cancer with CRISPR-Cas9: from genetic identification to clinical therapy
    Fan, Ping
    He, Zhi-Yao
    Xu, Ting
    Phan, Kevin
    Chen, George G.
    Wei, Yu-Quan
    TRANSLATIONAL CANCER RESEARCH, 2018, 7 (03) : 817 - 827
  • [17] identifying synthetic lethal targets in colon cancer using CRISPR-Cas9 and siRNA screens
    Russell, P.
    Walter, D.
    Yarker, J.
    Wiggins, C.
    Moore, J.
    EUROPEAN JOURNAL OF CANCER, 2016, 69 : S129 - S129
  • [18] Development and characterization of androgen receptor knockout prostate cancer cell lines by CRISPR-Cas9
    Zhu, Yezi
    Zhao, Pei
    Lu, Changxue
    Chen, Shihua
    Luo, Jun
    CANCER RESEARCH, 2018, 78 (13)
  • [19] CRISPR-Cas9: A Potent Gene-editing Tool for the Treatment of Cancer
    Mishra, Gauri
    Srivastava, Kamakshi
    Rais, Juhi
    Dixit, Manish
    Singh, Vandana Kumari
    Mishra, Lokesh Chandra
    CURRENT MOLECULAR MEDICINE, 2024, 24 (02) : 191 - 204
  • [20] A Duplex CRISPR-Cas9 Ribonucleoprotein Nanomedicine for Colorectal Cancer Gene Therapy
    Wan, Tao
    Pan, Qi
    Liu, Chongyi
    Guo, Jiajing
    Li, Bowen
    Yan, Xiaojie
    Cheng, Yiyun
    Ping, Yuan
    NANO LETTERS, 2021, 21 (22) : 9761 - 9771
12345